Furthermore, our long-term follow-up data in IPMN patients showed that BRSK2 also has a potential to accelerate the progression of IPMN, the early precursor of PDAC. The gene discussed is BRSK2; the disease is pancreatic intraductal papillary-mucinous neoplasm.